Opinion

New Tricks for Old Drugs? Canada must change how it accesses Essential Medicines

Leave a Comment

Your email address will not be published. Required fields are marked *

1 Comment
  • Cynthia Leung says:

    Thank you for writing this article. You summarize all the key points very well. Our Canadian drug supply is dependent on so many factors, none of which can be controlled by our own government. They are, however, influenced by others such as pharmaceutical marketing strategies, global influence. WE can’t talk about developing a list of essential medicine without having some assurance that these medicines can be consistently available to Canadians. We can’t suggest metformin is an essential medicine for diabetes when recalls are constantly happening. We can’t suggest ranitidine as first line option for GERD when 90% of market has been recalled. It’s time to pay attention and as you said, develop a sustainable strategy for accessing these essential medicines.

Author

Adam R. Houston

Contributor

Adam R. Houston is a Ph.D. student at the University of Ottawa working at the intersection of health and human rights law, with a particular interest in access to medicines and infectious disease.

Republish this article

Republish this article on your website under the creative commons licence.

Learn more